Brief: HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen
27/05/2026 12:57
BRIEF-HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen May 27 (Reuters) - HCW Biologics Inc HCWB.O:
EXERCISED OPTION TO REGAIN FULL RIGHTS FOR TWO COMMERCIAL-READY REAGENTS FROM WUGEN
BUYS RIGHTS FOR NO COST AND RETAINS 2.2 MILLION WUGEN SHARES
Source text: ID:nGNX5bDRx4
Further company coverage: HCWB.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Hcw Biologics
See all newsBrief: HCW Biologics Proposed Resale Of Up To 5.69 Million Shares Of Common Stock
Brief: HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen
Brief: HCW Biologics Prices Private Placement Of 2.8 Mln Units At $1.405 Per Unit
NASDAQ RESUMED AT 09:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM